Jasmohan S. Bajaj, is Professor of Medicine in the Division of Gastroenterology, Hepatology and Nutrition at Virginia Commonwealth University and Richmond VA Medical Center in Richmond, Virginia. Dr. Bajaj finished training in India, followed by Medicine and GI/Hepatology training in the United States. He also earned a master's degree in Epidemiology. Active in research, Dr. Bajaj has served as a principal investigator or co‐investigator for numerous clinical trials in hepatic encephalopathy, chronic liver disease, and microbiome. Dr.

I am an American, Spanish-trained physician, quadruple board-certified in Internal Medicine, Gastroenterology, Transplant Hepatology and Obesity Medicine. Since I joined the VA in August 2016, I have been pursuing the triple threat: to boost hepatology education of residents and fellows, to have clinical excellence, and to excel in hepatology research. My areas of interests are outcomes research in chronic liver diseases, acute-on-chronic liver diseases and prognostic modeling.

Transplant hepatologist and intensivist at Curry Cabral Hospital, Nova Medical School, Lisbon, Portugal. Master of science with research interests in acute liver failure, acute-on-chronic liver failure, and liver transplantation.

Dr. Anand V. Kulkarni is the senior consultant and director of critical care hepatology at the Asian Institute of Gastroenterology, Hyderabad, India. Has multiple national and international awards recognizing his contributions from AASLD, APASL, and ISG. He has more than 150 PubMed-indexed publications to his credit. His main areas of research focus include alcohol-associated hepatitis, ACLF, HCC and LDLT.

Dr. Apte is a Professor in the Department of Pharmacology, Toxicology and Therapeutics at the University of Kansas Medical Center in Kansas City, KS. Additionally, he serves as the Associate Director of the University of Kansas Liver Center and the Director of the Cells, Tissues, Bioanalysis and Biostatistics (CTBB) Core of Kansas Center for Metabolism and Obesity (KC-MORE). Dr. Apte's research is focused on mechanisms of drug-induced liver injury and regeneration, and adverse effects of environmental contaminants on the liver.

Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD is Chairman of the Global NASH/MASH Council (GNC) in Washington, DC, and Professor of Medicine and Chairman of the Global Center for Liver Outcomes & Policy Research at the Georgetown University School of Medicine in Washington, DC. Dr.

Claudia P. Oliveira, MD, PhD, FAASLD, is Associate Professor of the Department of Gastroenterology, University of São Paulo School of Medicine, Coordinator of Postgraduate Course of Department of Gastroenterology, University of São Paulo School of Medicine. Dra. Oliveira completed Residency in Internal Medicine, Gastroenterology, Hepatology Fellowship and PhD at University of Sao Paulo School of Medicine, where she became interested in hepatology research.

Dr. Díaz is an Assistant Professor at the University of California San Diego (UCSD). He is a Gastroenterology Specialist and also an Assistant Professor at the Pontificia Universidad Católica de Chile, School of Medicine. Trained as an Internal Medicine and Gastroenterology specialist at the Pontificia Universidad Católica de Chile. As a Clinical Researcher, he focuses on translational and clinical research in steatotic liver disease and liver transplantation.

Dr. Liangpunsakul is a Professor of Medicine, Biochemistry, and Molecular Biology in the Division of Gastroenterology and Hepatology at Indiana University. His research focuses on basic, translational, and clinical studies to determine the pathogenesis of alcohol-associated liver disease (ALD). He is the principal investigator of research projects funded by the US Department of Veterans Affairs (Merit Review) as well as the National Institutes of Health (NIH/NIAAA). He has authored or co-authored more than 250 peer-reviewed articles.

Marco Arrese, MD (Santiago, Chile, 1964) is Professor of Medicine and Head of the Department of Gastroenterology at Pontificia Universidad Catolica de Chile School of Medicine in Santiago. Trained in Chile and the U.S. (Yale University) he is an expert in liver diseases and have focused his research activities in both cholestatic and fatty liver diseases. He has published more than 250 peer-reviewed papers on gastrointestinal and liver diseases in high-impact factor journals and delivered lectures in national and international meetings.